Table 1

Patient response, survival time, and tumor staining characteristics in biochemotherapy protocol

Patient characteristics									Immunohistochemistry
Patient no.	Response	Survival time (mo)^a			Status	iNOS			NT
Patient no.	Response			First diagnosis^b	Status	First treatment day^c		Pretreatment	NT	Posttreatment
1	R^d	17	9	DOD	++	+++	−
2	NR	20	14	DOD	N/A	++	++
3	R	33	32	DOD	N/A	++	++
4	NR	21	17	DOD	−	+	−
5	NR	59	18	DOD	++	+++	++
6	R	?	19	DOD	N/A	++	++
7	NR	40	22	DOD	N/A	++	+
8	NR	29	28	DOD	N/A	+	−
9	NR	26	25	DOD	++	+	++
10	NR	30	29	DOD	++	+++	+++
11	NR	67	44	DOD	N/A	++	++
12	NR	?	48	DOD	N/A	−	−
15	R	54+	53+	ANED	N/A	−	−
16	NR	74+	56+	AWD	−	−	−
13	NR	72+	61+	AWD	−	−	−
14	NR	74+	61+	ANED	N/A	−	−
20	R	69+	60+	ANED	−	−	−
17	R	99+	65+	ANED	N/A	−	−
19	NR	?	65+	ANED	−	−	−
18	R	92+	66+	ANED	+++	++	+++

^a–c Survival measured from:
^b the date of primary tumor diagnosis, and
^c the initiation of treatment.
^d R, major response; NR, absence of major response; DOD, dead of disease; ANED, alive with no evidence of disease; AWD, alive with disease; N/A, not available; ?, not known.